Conflicts of Interest: Ms. Wong, Dr. Heller, and Dr. Murase report no conflicts of interest. No funding supported the production of this manuscript.
Safety classification systems used in dermatological medication risk counseling of pregnant and lactating patients: a case for an evidence-based approach
Version of Record online: 5 AUG 2013
© 2013 Wiley Periodicals, Inc.
Special Issue: Treatment of Cutaneous Disorders of Pregnancy
Volume 26, Issue 4, pages 347–353, July/August 2013
How to Cite
Millsop, J. W., Heller, M. M. and Murase, J. E. (2013), Safety classification systems used in dermatological medication risk counseling of pregnant and lactating patients: a case for an evidence-based approach. Dermatologic Therapy, 26: 347–353. doi: 10.1111/dth.12015
- Issue online: 5 AUG 2013
- Version of Record online: 5 AUG 2013
This article has been cited by:
- 1Drug safety: Pregnancy rating classifications and controversies, Clinics in Dermatology, 2016, 34, 3, 401, , ,
- 2Rheumatoid arthritis and pregnancy, Current Opinion in Rheumatology, 2014, 26, 3, 341, ,
- 3Tumor necrosis factor-alfa inhibitors in pregnancy: To prescribe, or not to prescribe, that is the question, Journal of the American Academy of Dermatology, 2014, 71, 4, 831, ,